Skip to main content
. Author manuscript; available in PMC: 2022 Feb 24.
Published in final edited form as: Eur J Pharmacol. 2020 Jan 31;873:172981. doi: 10.1016/j.ejphar.2020.172981

Fig 3. Characterization of MAF1329 ependymoma cells.

Fig 3.

(A) Circos plot depiction of tumor genome MAF1329 (B) Western blot analysis confirmed presence of wild type RELA as well as C11orf95-RELA fusion protein in ependymoma primary cell culture MAF1329. (C) Cell viability of MAF1329 cells treated with NF-κB antagonists specifically targeting IκBα phosphorylation.